Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALLO | REPL | ANRO | ||
| Company | Allogene Therapeutics Inc | Replimune Group Inc | Alto Neuroscience Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 2.63 | 7.43 | 19.35 | ||
| High | 2.72 | 7.57 | 21.56 | ||
| Low | 2.54 | 7.02 | 19.16 | ||
| Latest | 2.65 | 7.16 | 20.63 | ||
| Change | -0.13 | -0.49 | +0.94 | ||
| % Change | -4.68% | -6.41% | +4.77% | ||
| Volume | 3,807,600 | 1,556,600 | 267,300 | ||
| 20-Day Average Volume | 5,865,845 | 1,280,040 | 229,445 | ||
| Previous Close | 2.78 | 7.65 | 19.69 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.04 | 7.76 | 17.53 | ||
| 20-Day Raw Stochastic | 87.90% | 18.63% | 87.84% | ||
| 20-Day Relative Strength | 68.62 | 41.96 | 62.18 | ||
| Weighted Alpha | +73.51 | -0.65 | +168.95 | ||
| Today's Opinion | 100% Buy | 48% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 24% Sell | 88% Buy | ||
| Last Month's Opinion | 96% Buy | 24% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +27.40% since 02/23/26 | -14.66% since 02/23/26 | +12.73% since 02/23/26 | ||
| Low | 2.10 on 02/24/26 | 7.02 on 03/02/26 | 18.00 on 02/24/26 | ||
| High | 2.80 on 02/27/26 | 8.60 on 02/24/26 | 21.56 on 03/02/26 | ||
| 1-Month | |||||
| %Chg | +41.71% since 02/02/26 | +2.65% since 02/02/26 | +30.49% since 02/02/26 | ||
| Low | 1.56 on 02/12/26 | 6.78 on 02/04/26 | 13.91 on 02/06/26 | ||
| High | 2.80 on 02/27/26 | 8.82 on 02/23/26 | 21.56 on 03/02/26 | ||
| 3-Month | |||||
| %Chg | +97.76% since 12/02/25 | -28.40% since 12/02/25 | +61.17% since 12/02/25 | ||
| Low | 1.29 on 12/30/25 | 6.77 on 01/20/26 | 12.51 on 12/09/25 | ||
| High | 2.80 on 02/27/26 | 11.09 on 12/08/25 | 21.56 on 03/02/26 | ||
| 6-Month | |||||
| %Chg | +136.61% since 09/02/25 | +21.36% since 09/02/25 | +431.70% since 09/02/25 | ||
| Low | 1.04 on 11/07/25 | 3.12 on 09/22/25 | 3.41 on 09/04/25 | ||
| High | 2.80 on 02/27/26 | 11.26 on 12/02/25 | 21.56 on 03/02/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 624,749 | 631,683 | 611,689 | ||
| Shares Outstanding, K | 224,730 | 82,573 | 31,066 | ||
| Annual Sales | 20,000 | 0 | 0 | ||
| Annual Net Income | -257,590,000 | -247,300,000 | -61,430,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -41,400,000 | -70,930,000 | -14,180,000 | ||
| 60-Month Beta | 0.60 | 0.73 | 2.78 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.19 on 11/06/25 | -0.90 on 11/06/25 | -0.52 on 11/12/25 | ||
| Latest Earnings Date | 03/12/26 | 05/28/26 | 03/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||